Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Radiation Dose and Volume to the Pancreas and Subsequent Risk of Diabetes Mellitus.

Friedman DN, Moskowitz CS, Hilden P, Howell RM, Weathers RE, Smith SA, Wolden SL, Tonorezos ES, Mostoufi-Moab S, Chow EJ, Meacham LR, Chou JF, Whitton JA, Leisenring WM, Robison LL, Armstrong GT, Oeffinger KC, Sklar CA.

J Natl Cancer Inst. 2019 Jul 22. pii: djz152. doi: 10.1093/jnci/djz152. [Epub ahead of print]

PMID:
31329225
2.

Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.

Moskowitz CS, Chou JF, Neglia JP, Partridge AH, Howell RM, Diller LR, Novetsky Friedman D, Barnea D, Morton LM, Turcotte LM, Arnold MA, Leisenring WM, Armstrong GT, Robison LL, Oeffinger KC, Henderson TO.

J Clin Oncol. 2019 Jul 1:JCO1802219. doi: 10.1200/JCO.18.02219. [Epub ahead of print]

PMID:
31260644
3.

Promoting Breast Cancer Surveillance: The EMPOWER Study, a Randomized Clinical Trial in the Childhood Cancer Survivor Study.

Oeffinger KC, Ford JS, Moskowitz CS, Chou JF, Henderson TO, Hudson MM, Diller L, McDonald A, Ford J, Mubdi NZ, Rinehart D, Vukadinovich C, Gibson TM, Anderson N, Elkin EB, Garrett K, Rebull M, Leisenring W, Robison LL, Armstrong GT.

J Clin Oncol. 2019 Jul 1:JCO1900547. doi: 10.1200/JCO.19.00547. [Epub ahead of print]

PMID:
31260642
4.

Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer.

Won E, Basunia A, Chatila WK, Hechtman JF, Chou JF, Ku GY, Chalasani SB, Boyar MS, Goldberg Z, Desai AM, Tuvy Y, Berger MF, Tang L, Kelsen DP, Schattner M, Ilson DH, Capanu M, Solit DB, Schultz N, Janjigian YY.

Clin Cancer Res. 2019 Jul 1;25(13):3811-3817. doi: 10.1158/1078-0432.CCR-18-3789. Epub 2019 Apr 5.

PMID:
30952642
5.

Binimetinib plus Gemcitabine and Cisplatin Phase I/II Trial in Patients with Advanced Biliary Cancers.

Lowery MA, Bradley M, Chou JF, Capanu M, Gerst S, Harding JJ, Dika IE, Berger M, Zehir A, Ptashkin R, Wong P, Rasalan-Ho T, Yu KH, Cercek A, Morgono E, Salehi E, Valentino E, Hollywood E, O'Reilly EM, Abou-Alfa GK.

Clin Cancer Res. 2019 Feb 1;25(3):937-945. doi: 10.1158/1078-0432.CCR-18-1927. Epub 2018 Dec 18.

PMID:
30563938
6.

Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma.

Yu KH, Ricigliano M, McCarthy B, Chou JF, Capanu M, Cooper B, Bartlett A, Covington C, Lowery MA, O'Reilly EM.

Cancers (Basel). 2018 Nov 24;10(12). pii: E467. doi: 10.3390/cancers10120467.

7.

Positron-Emission Tomography Scan-Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron-Emission Tomography Nonresponders.

Greally M, Chou JF, Molena D, Rusch VW, Bains MS, Park BJ, Wu AJ, Goodman KA, Kelsen DP, Janjigian YY, Ilson DH, Ku GY.

J Thorac Oncol. 2019 Mar;14(3):540-546. doi: 10.1016/j.jtho.2018.10.152. Epub 2018 Nov 1.

PMID:
30391577
8.

Multifocal/Multicentric Ipsilateral Invasive Breast Carcinomas with Similar Histology: Is Multigene Testing of All Individual Foci Necessary?

Grabenstetter A, Brogi E, Chou JF, Morrow M, Dickler M, Norton L, Wen HY.

Ann Surg Oncol. 2019 Feb;26(2):329-335. doi: 10.1245/s10434-018-6866-y. Epub 2018 Oct 8.

PMID:
30298311
9.

Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer.

Mondaca S, Margolis M, Sanchez-Vega F, Jonsson P, Riches JC, Ku GY, Hechtman JF, Tuvy Y, Berger MF, Shah MA, Kelsen DP, Ilson DH, Yu K, Goldberg Z, Epstein AS, Desai A, Chung V, Chou JF, Capanu M, Solit DB, Schultz N, Janjigian YY.

Gastric Cancer. 2019 Mar;22(2):355-362. doi: 10.1007/s10120-018-0861-7. Epub 2018 Aug 7.

PMID:
30088161
10.

Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior.

Sahin IH, Elias H, Chou JF, Capanu M, O'Reilly EM.

BMC Cancer. 2018 Jul 28;18(1):769. doi: 10.1186/s12885-018-4679-9.

11.

Vision-Targeted Health-Related Quality of Life in Adult Survivors of Retinoblastoma.

Friedman DN, Chou JF, Francis JH, Sklar CA, Li Y, McCabe M, Robison LL, Kleinerman RA, Oeffinger KC, Abramson DH, Dunkel IJ, Ford JS.

JAMA Ophthalmol. 2018 Jun 1;136(6):637-641. doi: 10.1001/jamaophthalmol.2018.1082.

12.

Adrenal Metastasectomy in the Presence and Absence of Extraadrenal Metastatic Disease.

Russo AE, Untch BR, Kris MG, Chou JF, Capanu M, Coit DG, Chaft JE, D'Angelica MI, Brennan MF, Strong VE.

Ann Surg. 2019 Aug;270(2):373-377. doi: 10.1097/SLA.0000000000002749.

PMID:
29578911
13.

Cerebellar α6 -subunit-containing GABAA receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders.

Chiou LC, Lee HJ, Ernst M, Huang WJ, Chou JF, Chen HL, Mouri A, Chen LC, Treven M, Mamiya T, Fan PC, Knutson DE, Witzigmann C, Cook J, Sieghart W, Nabeshima T.

Br J Pharmacol. 2018 Jun;175(12):2414-2427. doi: 10.1111/bph.14198. Epub 2018 May 10.

14.

Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?

Creasy JM, Sadot E, Koerkamp BG, Chou JF, Gonen M, Kemeny NE, Balachandran VP, Kingham TP, DeMatteo RP, Allen PJ, Blumgart LH, Jarnagin WR, D'Angelica MI.

Surgery. 2018 Jun;163(6):1238-1244. doi: 10.1016/j.surg.2018.01.004. Epub 2018 Feb 15.

PMID:
29455841
15.

Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma.

Harding JJ, Abu-Zeinah G, Chou JF, Owen DH, Ly M, Lowery MA, Capanu M, Do R, Kemeny NE, O'Reilly EM, Saltz LB, Abou-Alfa GK.

J Natl Compr Canc Netw. 2018 Jan;16(1):50-58. doi: 10.6004/jnccn.2017.7024.

PMID:
29295881
16.

The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.

Creasy JM, Sadot E, Koerkamp BG, Chou JF, Gonen M, Kemeny NE, Saltz LB, Balachandran VP, Peter Kingham T, DeMatteo RP, Allen PJ, Jarnagin WR, D'Angelica MI.

Ann Surg Oncol. 2018 Feb;25(2):431-438. doi: 10.1245/s10434-017-6264-x. Epub 2017 Nov 27.

PMID:
29181680
17.

Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.

Pak LM, Kemeny NE, Capanu M, Chou JF, Boucher T, Cercek A, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI.

J Surg Oncol. 2018 Mar;117(4):634-643. doi: 10.1002/jso.24898. Epub 2017 Nov 22.

18.

21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.

Turashvili G, Chou JF, Brogi E, Morrow M, Dickler M, Norton L, Hudis C, Wen HY.

Breast Cancer Res Treat. 2017 Nov;166(1):69-76. doi: 10.1007/s10549-017-4381-7. Epub 2017 Jul 12.

19.

CHSY1 promotes aggressive phenotypes of hepatocellular carcinoma cells via activation of the hedgehog signaling pathway.

Liu CH, Lan CT, Chou JF, Tseng TJ, Liao WC.

Cancer Lett. 2017 Sep 10;403:280-288. doi: 10.1016/j.canlet.2017.06.023. Epub 2017 Jun 23.

PMID:
28652022
20.

Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.

Zheng J, Chou JF, Gönen M, Vachharajani N, Chapman WC, Majella Doyle MB, Turcotte S, Vandenbroucke-Menu F, Lapointe R, Buettner S, Groot Koerkamp B, Ijzermans JNM, Chan CY, Goh BKP, Teo JY, Kam JH, Jeyaraj PR, Cheow PC, Chung AYF, Chow PKH, Ooi LLPJ, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Lee SY.

Ann Surg. 2017 Oct;266(4):693-701. doi: 10.1097/SLA.0000000000002360.

PMID:
28650354
21.

Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study.

Moskowitz CS, Chou JF, Sklar CA, Barnea D, Ronckers CM, Friedman DN, Neglia JP, Turcotte L, Howell RM, Henderson TO, Armstrong GT, Leisenring WM, Robison LL, van Leeuwen FE, Pike MC, Oeffinger KC.

Br J Cancer. 2017 Jul 11;117(2):290-299. doi: 10.1038/bjc.2017.169. Epub 2017 Jun 20.

22.

O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors.

Raj N, Klimstra DS, Horvat N, Zhang L, Chou JF, Capanu M, Basturk O, Do RKG, Allen PJ, Reidy-Lagunes D.

Pancreas. 2017 Jul;46(6):758-763. doi: 10.1097/MPA.0000000000000842.

23.

A Comparison of Yttrium-90 Microsphere Radioembolization to Hepatic Arterial Infusional Chemotherapy for Patients with Chemo-refractory Hepatic Colorectal Metastases.

Cercek A, Gendel V, Jabbour S, Moore D, Chen C, Nosher J, Capanu M, Chou JF, Boucher T, Kemeny N, Carpizo DR.

Curr Treat Options Oncol. 2017 Jul;18(7):42. doi: 10.1007/s11864-017-0481-1.

PMID:
28608276
24.

Clinical Features and Outcomes of Patients with Colorectal Cancers Harboring NRAS Mutations.

Cercek A, Braghiroli MI, Chou JF, Hechtman JF, Kemeny N, Saltz L, Capanu M, Yaeger R.

Clin Cancer Res. 2017 Aug 15;23(16):4753-4760. doi: 10.1158/1078-0432.CCR-17-0400. Epub 2017 Apr 26.

25.

Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience.

Friedman DN, Chastain K, Chou JF, Moskowitz CS, Adsuar R, Wexler LH, Chou AJ, DeRosa A, Candela J, Magnan H, Pun S, Kahan T, Wolden SL, Meyers PA, Oeffinger KC.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26562. Epub 2017 Apr 18.

PMID:
28417551
26.

Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.

Bowers DC, Moskowitz CS, Chou JF, Mazewski CM, Neglia JP, Armstrong GT, Leisenring WM, Robison LL, Oeffinger KC.

J Clin Oncol. 2017 May 10;35(14):1570-1576. doi: 10.1200/JCO.2016.70.1896. Epub 2017 Mar 24.

27.

Screening for thyroid cancer in survivors of childhood and young adult cancer treated with neck radiation.

Tonorezos ES, Barnea D, Moskowitz CS, Chou JF, Sklar CA, Elkin EB, Wong RJ, Li D, Tuttle RM, Korenstein D, Wolden SL, Oeffinger KC.

J Cancer Surviv. 2017 Jun;11(3):302-308. doi: 10.1007/s11764-016-0588-6. Epub 2016 Dec 27.

28.

Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.

Connell LC, Boucher TM, Chou JF, Capanu M, Maldonado S, Kemeny NE.

J Surg Oncol. 2017 Mar;115(4):480-487. doi: 10.1002/jso.24536. Epub 2016 Dec 23.

29.

Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.

Cercek A, Boucher TM, Gluskin JS, Aguiló A, Chou JF, Connell LC, Capanu M, Reidy-Lagunes D, D'Angelica M, Kemeny NE.

J Surg Oncol. 2016 Nov;114(6):655-663. doi: 10.1002/jso.24399. Epub 2016 Aug 26.

30.

Redistribution of Cav2.1 channels and calcium ions in nerve terminals following end-to-side neurorrhaphy: ionic imaging analysis by TOF-SIMS.

Liu CH, Chang HM, Tseng TJ, Lan CT, Chen LY, Youn SC, Lee JJ, Mai FD, Chou JF, Liao WC.

Histochem Cell Biol. 2016 Nov;146(5):599-608. Epub 2016 Jul 28.

PMID:
27468821
31.

Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis.

Landau H, Smith M, Landry C, Chou JF, Devlin SM, Hassoun H, Bello C, Giralt S, Comenzo RL.

Leukemia. 2017 Jan;31(1):136-142. doi: 10.1038/leu.2016.229. Epub 2016 Aug 18.

32.

Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy.

Kemeny NE, Chou JF, Boucher TM, Capanu M, DeMatteo RP, Jarnagin WR, Allen PJ, Fong YC, Cercek A, D'Angelica MI.

J Surg Oncol. 2016 Apr;113(5):477-84. doi: 10.1002/jso.24189. Epub 2016 Feb 2.

33.

Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.

Friedman DN, Chou JF, Oeffinger KC, Kleinerman RA, Ford JS, Sklar CA, Li Y, McCabe MS, Robison LL, Marr BP, Abramson DH, Dunkel IJ.

Cancer. 2016 Mar 1;122(5):773-81. doi: 10.1002/cncr.29704. Epub 2016 Jan 11.

34.

Patterns and Predictors of Weight Loss After Gastrectomy for Cancer.

Davis JL, Selby LV, Chou JF, Schattner M, Ilson DH, Capanu M, Brennan MF, Coit DG, Strong VE.

Ann Surg Oncol. 2016 May;23(5):1639-45. doi: 10.1245/s10434-015-5065-3. Epub 2016 Jan 5.

35.

Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study.

Henderson TO, Moskowitz CS, Chou JF, Bradbury AR, Neglia JP, Dang CT, Onel K, Novetsky Friedman D, Bhatia S, Strong LC, Stovall M, Kenney LB, Barnea D, Lorenzi E, Hammond S, Leisenring WM, Robison LL, Armstrong GT, Diller LR, Oeffinger KC.

J Clin Oncol. 2016 Mar 20;34(9):910-8. doi: 10.1200/JCO.2015.62.3314. Epub 2015 Dec 23.

36.

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D.

J Clin Oncol. 2016 Feb 20;34(6):557-65. doi: 10.1200/JCO.2015.63.0830. Epub 2015 Dec 7. Erratum in: J Clin Oncol. 2016 Jun 20;34(18):2198. Erratum in: J Clin Oncol. 2019 Feb 20;37(6):528.

37.

Intensity modulated radiation therapy reduces gastrointestinal toxicity in locally advanced pancreas cancer.

Prasad S, Cambridge L, Huguet F, Chou JF, Zhang Z, Wu AJ, O'Reilly EM, Allen PJ, Goodman KA.

Pract Radiat Oncol. 2016 Mar-Apr;6(2):78-85. doi: 10.1016/j.prro.2015.09.006. Epub 2015 Sep 25.

38.

Psychosocial Outcomes in Adult Survivors of Retinoblastoma.

Ford JS, Chou JF, Sklar CA, Oeffinger KC, Novetsky Friedman D, McCabe M, Robison LL, Kleinerman RA, Li Y, Marr BP, Abramson DH, Dunkel IJ.

J Clin Oncol. 2015 Nov 1;33(31):3608-14. doi: 10.1200/JCO.2014.60.5733. Epub 2015 Sep 28.

39.

Breast cancer following spinal irradiation for a childhood cancer: A report from the Childhood Cancer Survivor Study.

Moskowitz CS, Malhotra J, Chou JF, Wolden SL, Weathers RE, Stovall M, Armstrong GT, Leisenring WM, Neglia JP, Robison LL, Oeffinger KC.

Radiother Oncol. 2015 Nov;117(2):213-6. doi: 10.1016/j.radonc.2015.09.016. Epub 2015 Sep 18.

40.

Central hepatectomy versus extended hepatectomy for liver malignancy: a matched cohort comparison.

Lee SY, Sadot E, Chou JF, Gönen M, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI.

HPB (Oxford). 2015 Nov;17(11):1025-32. doi: 10.1111/hpb.12507. Epub 2015 Sep 10.

41.

Health care utilization, lifestyle, and emotional factors and mammography practices in the Childhood Cancer Survivor Study.

Rosenberg SM, Moskowitz CS, Ford JS, Henderson TO, Frazier AL, Diller LR, Hudson MM, Stanton AL, Chou JF, Smith S, Leisenring WM, Mertens AC, Cox CL, Nathan PC, Krull KR, Robison LL, Oeffinger KC.

Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1699-706. doi: 10.1158/1055-9965.EPI-14-1377. Epub 2015 Aug 24.

42.

Corpus Callosum Diffusion and Language Lateralization in Patients with Brain Tumors: A DTI and fMRI Study.

Tantillo G, Peck KK, Arevalo-Perez J, Lyo JK, Chou JF, Young RJ, Brennan NP, Holodny AI.

J Neuroimaging. 2016 Mar-Apr;26(2):224-31. doi: 10.1111/jon.12275. Epub 2015 Aug 10.

43.

Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma.

Wang SC, Chou JF, Strong VE, Brennan MF, Capanu M, Coit DG.

Ann Surg. 2016 Feb;263(2):292-7. doi: 10.1097/SLA.0000000000001189.

44.

[Nursing care for ovarian cancer patients with intraperitoneal chemotherapy].

Lu YY, Chou JF, Tsao LI, Liang SY, Wu SF.

Hu Li Za Zhi. 2015 Feb;62(1):87-91. doi: 10.6224/JN.62.1.87. Chinese.

PMID:
25631188
45.

Laparoscopic Versus Open Gastrectomy for Gastric Adenocarcinoma in the West: A Case-Control Study.

Kelly KJ, Selby L, Chou JF, Dukleska K, Capanu M, Coit DG, Brennan MF, Strong VE.

Ann Surg Oncol. 2015 Oct;22(11):3590-6. doi: 10.1245/s10434-015-4381-y. Epub 2015 Jan 29.

46.

RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer.

Yaeger R, Cowell E, Chou JF, Gewirtz AN, Borsu L, Vakiani E, Solit DB, Rosen N, Capanu M, Ladanyi M, Kemeny N.

Cancer. 2015 Apr 15;121(8):1195-203. doi: 10.1002/cncr.29196. Epub 2014 Dec 9.

47.

Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer.

Cercek A, Shia J, Gollub M, Chou JF, Capanu M, Raasch P, Reidy-Lagunes D, Proia DA, Vakiani E, Solit DB, Saltz LB.

Clin Colorectal Cancer. 2014 Dec;13(4):207-12. doi: 10.1016/j.clcc.2014.09.001. Epub 2014 Sep 21.

48.

KIR and HLA genotypes have no identifiable role in single-unit dominance following double-unit umbilical cord blood transplantation.

Tarek N, Gallagher MM, Chou JF, Lubin MN, Heller G, Barker JN, Hsu KC.

Bone Marrow Transplant. 2015 Jan;50(1):150-2. doi: 10.1038/bmt.2014.218. Epub 2014 Oct 13. No abstract available.

49.

KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases.

Kemeny NE, Chou JF, Capanu M, Gewirtz AN, Cercek A, Kingham TP, Jarnagin WR, Fong YC, DeMatteo RP, Allen PJ, Shia J, Ang C, Vakiani E, D'Angelica MI.

Cancer. 2014 Dec 15;120(24):3965-71. doi: 10.1002/cncr.28954. Epub 2014 Aug 25.

50.

Breast cancer after chest radiation therapy for childhood cancer.

Moskowitz CS, Chou JF, Wolden SL, Bernstein JL, Malhotra J, Novetsky Friedman D, Mubdi NZ, Leisenring WM, Stovall M, Hammond S, Smith SA, Henderson TO, Boice JD, Hudson MM, Diller LR, Bhatia S, Kenney LB, Neglia JP, Begg CB, Robison LL, Oeffinger KC.

J Clin Oncol. 2014 Jul 20;32(21):2217-23. doi: 10.1200/JCO.2013.54.4601. Epub 2014 Apr 21.

Supplemental Content

Support Center